The effect of MK-185 on some aspects of uric acid metabolism.
D000493:Allopurinol / Q000494:pharmacology; D000577:Amides / Q000494:pharmacology; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001555:Benzene Derivatives / Q000494:pharmacology; D002994:Clofibrate / Q000494:pharmacology; D006801:Humans; D006937:Hypercholesterolemia / Q000652:urine*; D008055:Lipids / Q000097:blood; D010919:Placebos; D011339:Probenecid / Q000494:pharmacology; D011422:Propionates / Q000494:pharmacology*; D011687:Purines / Q000652:urine; D014527:Uric Acid / Q000097:blood / Q000378:metabolism* / Q000652:urine
D000577:Amides; D000924:Anticholesteremic Agents; D001555:Benzene Derivatives; D008055:Lipids; D010919:Placebos; D011422:Propionates; D011687:Purines; D014527:Uric Acid; D000493:Allopurinol; D002994:Clofibrate; D011339:Probenecid